Tag Archives: The Stem Cell Blog

Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022 – PR Newswire (press release)

Continue reading

2017-04-24 NEWS

Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022
PR Newswire (press release)
“Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022” report gives comprehensive insight on clinical and non-clinical developments in the field …

and more »

Continue reading

2017-04-24 NEWS

Drs. Oz and Roizen: Put diabetes in remission; beware of stemcell treatments for AMD
News Sentinel
Q: I hear there’s a clinic in Canada that can medically cure Type 2 diabetes without bariatric surgery. I was diagnosed two years ago. Is this true? — William T., Bozeman, Mont. A: It’s almost true. Because Type 2 is a chronic disease, when you have

and more »

Continue reading

2017-04-24 NEWS

MIT Technology Review

Immunotherapy Pioneer James Allison Has Unfinished Business …
MIT Technology Review
On the day I arrive at MD Anderson Cancer Center in Houston to meet James Allison and his longtime collaborator Padmanee Sharma, they are nowhere to be …
CRISPR genome editing and immunotherapy – the early adopterMedical Xpress
Cancer immunotherapy market forecast to 2021 available in new …WhaTech

all 5 news articles »

Continue reading

2017-04-24 NEWS

Pittsburgh Post-Gazette

In Pittsburgh, oral immunotherapy treatment for allergies in its infancy
Pittsburgh Post-Gazette
Six-year-old Eva of Mt. Lebanon is one of just a few children in Pittsburgh receiving oral immunotherapy (OIT) for a peanut allergy. Dissolved inside Eva’s fruit punch Kool-Aid was a minuscule amount of peanut powder. Two months ago, it would have …

Continue reading

2017-04-24 NEWS

Genetic Engineering & Biotechnology News (press release)

Streamlining Stem Cell Manufacturing
Genetic Engineering & Biotechnology News (press release)
Stem cell therapies hold extraordinary potential to revolutionize human medicine. Indeed, the global market for cell-based therapies is expected to surpass $20 billion by 2025, with an annual growth rate of 21%, as estimated by Scientia Advisors